Profile	GDS4460 / 232119_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	25.5	45
GSM803589	patient 7, baseline	14.3	31
GSM803592	patient 8, baseline	17.2	33
GSM803595	patient 10, baseline	16.3	28
GSM803598	patient 11, baseline	19.8	39
GSM803601	patient 12, baseline	13.3	28
GSM803604	patient 13, baseline	22.3	42
GSM803607	patient 14, baseline	20.4	37
GSM803610	patient 15, baseline	27.1	45
GSM803613	patient 16, baseline	19.5	38
GSM803587	patient 6, arm treated with pimecrolimus	11.4	28
GSM803590	patient 7, arm treated with pimecrolimus	17.9	36
GSM803593	patient 8, arm treated with pimecrolimus	14.1	29
GSM803605	patient 13, arm treated with pimecrolimus	7.2	21
GSM803608	patient 14, arm treated with pimecrolimus	17.7	36
GSM803599	patient 11, arm treated with pimecrolimus	14.2	31
GSM803611	patient 15, arm treated with pimecrolimus	20.4	39
GSM803614	patient 16, arm treated with pimecrolimus	10.6	27
GSM803602	patient 12, arm treated with pimecrolimus	26.3	40
GSM803596	patient 10, arm treated with pimecrolimus	24.5	36
GSM803591	patient 8, arm treated with betamethasone	9.6	25
GSM803609	patient 15, arm treated with betamethasone	28	39
GSM803597	patient 11, arm treated with betamethasone	18.9	32
GSM803585	patient 6, arm treated with betamethasone	23.6	36
GSM803603	patient 13, arm treated with betamethasone	44	53
GSM803612	patient 16, arm treated with betamethasone	28.2	44
GSM803588	patient 7, arm treated with betamethasone	44.8	52
GSM803594	patient 10, arm treated with betamethasone	7.5	20
GSM803600	patient 12, arm treated with betamethasone	36.6	47
GSM803606	patient 14, arm treated with betamethasone	44	54